REQUEST A DEMO
Total
USD $0.00
Search more companies

Cong Ty Co Phan Duoc Pham Trung Uong Codupha (Vietnam)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Cong Ty Co Phan Duoc Pham Trung Uong Codupha Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

TW2 Pharmaceutical Company, located in Ho Chi Minh municipality, was established on November 26, 1975, after the reunification of the country. Initially known as General Pharmaceutical Depot, the company's main function was to distribute finished drugs, raw materials, chemicals, and medical equipment for the prevention and treatment system in the South. In 1976, the company split into two separate entities: a medical equipment and laboratory chemicals company, and Tier 1 Pharmaceutical Company, which retained the trading name CODUPHA. CODUPHA, an abbreviation of La Compagnie Du Pharmacetique, became one of two state-owned pharmaceutical companies responsible for distributing drugs, raw materials, chemicals, and medical equipment in the Southern region. In 1985, Tier 1 Pharmaceutical Company changed its name to Central Pharmaceutical Company No. 2 while still operating under the trading name CODUPHA. In 1993, Central Pharmaceutical Company No. 2 became a state-owned enterprise under the Vietnam Union of Pharmaceutical Enterprises, now known as Vietnam Pharmaceutical Corporation (Vinapharm), under the supervision of the Ministry of Health. CODUPHA was granted an import license in 1993. Over the years, CODUPHA expanded its operations by establishing branches in Hanoi, Can Tho city, Buon Ma Thuot city, Vinh city, Hai Phong, and Quang Ngai. These branches provided medicines and medical products to various regions in Vietnam. In 2002, CODUPHA invested in building a pharmaceutical factory in Lao PDR that meets the standards of the World Health Organization's Good Manufacturing Practices (GMP). In 2010, Central Pharmaceutical Company No. 2 transformed into TW2 Pharmaceutical One Member Limited Liability Company, operating under the trading name CODUPHA, as per the government's decree. The company is registered under Business Registration Certificate No. 2 issued by the Department of Planning and Investment.

Headquarters
Building 509 - 515 To Hien Thanh Str, Ward 14, Dist. 10
Ho Chi Minh municipality; South Eastern Vietnam; Postal Code: 70

Contact Details: Purchase the Cong Ty Co Phan Duoc Pham Trung Uong Codupha report to view the information.

Website: http://www.codupha.com.vn

Basic Information
Total Employees:
Purchase the Cong Ty Co Phan Duoc Pham Trung Uong Codupha report to view the information.
Outstanding Shares:
Purchase the Cong Ty Co Phan Duoc Pham Trung Uong Codupha report to view the information.
Financial Auditors:
Purchase the Cong Ty Co Phan Duoc Pham Trung Uong Codupha report to view the information.
Incorporation Date:
1975
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Vice Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
19%
Subsidiaries
Cong Ty Tnhh Duoc Pham Codupha - Lao (Laos)
93.7%
Company Performance
Financial values in the chart are available after Cong Ty Co Phan Duoc Pham Trung Uong Codupha report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.
Net sales revenue
0.59%
Total operating revenue
0.59%
Operating profit (EBIT)
-12%
EBITDA
-4.58%
Net Profit (Loss) for the Period
-60.31%
Total assets
2.43%
Total equity
-0.7%
Operating Profit Margin (ROS)
-0.17%
Net Profit Margin
-0.46%
Return on Equity (ROE)
-6.78%
Debt to Equity Ratio
40.25%
Quick Ratio
-0.05%
Cash Ratio
0.01%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?